In conclusion, the present results showed that LMO4 is overexpressed in pancreatic cancer related to both the PanIN-conventional IDC pathway and the IPMA-IPMC pathway, but not at the early stages of pancreatic carcinogenesis. Here, LMO4 is linked to pancreatic neoplasm.